RESUMEN
The authors assessed efficacy and safety of class 2 compression knitwear VENOTEKS TREND used in conservative and injection phlebosclerosing therapy of patients presenting with clinical class C1-C3 chronic venous diseases of the lower limbs. The study included a total of 30 patients. The compliance rate amounted to 92%. It was demonstrated that class 2 compression knitwear Venoteks Trend statistically significantly decreases the degree of subjective symptomatology, is efficient and safe in therapy for oedematous syndrome in the programmes of conservative treatment and after sclerotherapy.
Asunto(s)
Extremidad Inferior/irrigación sanguínea , Escleroterapia/métodos , Medias de Compresión , Insuficiencia Venosa , Adulto , Enfermedad Crónica , Investigación sobre la Eficacia Comparativa , Tratamiento Conservador/métodos , Femenino , Humanos , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Venas/fisiopatología , Insuficiencia Venosa/diagnóstico , Insuficiencia Venosa/fisiopatología , Insuficiencia Venosa/terapiaRESUMEN
The authors assessed the effect of a micronized purified flavonoid fraction (MPFF) on the course of the postoperative period after endovenous thermal ablation (EVTA). The patients of the Study Group matching by the main studied parameters to the Control Group patients were given the MPFF according to the suggested regimen for 7 days. The obtained results were analysed by means of questionnaires (CIVIQ, VCSS, VAS) and ultrasound angioscanning. The obtained findings were statistically processed by means of the program Statistica 6.0 and reliability of the results was assessed with the help of the Student t-test. Patients of the both groups showed complete stable obliteration of the target veins. No statistically significant differences of the items of the questionnaires CIVIQ and VCSS at the beginning of the study and at the last examination were revealed, differences were noted on days 2-14 after EVTA and were not statistically significant (p>0.05). Phlebotrophic therapy in the postoperative period after EVTA helps to decrease phlebitic alterations in the coagulated vein, to improve motor activity and mental psychoemotional state of the patients.